The Latest Breaking News on Pharma

COVID-19 cases are soaring across Australia as a fourth wave passes through and authorities begin urging people to mask up.

Favorable inflation data for October has raised the odds of slower federal rate hikes ahead. The market has been celebrating the inflation report, and experts believe the current rally could sustain for a while. Therefore, investors could buy quality stocks such as Gilead Sciences (GILD), Biogen (BIIB), Hillenbrand (HI), and…

Squabbles and gossip seem to plague the sunrise pharmaceutical industry – why?

The revolutionary DCVax-L vaccine has allowed Nigel French to live a normal life seven years after a brain cancer diagnosis

A cut in drug prices for some Medicare beneficiaries kicks in next year, but finding those savings isn't easy

This money will make a huge difference to Northern Ireland

Nicola Ryan has now received an award for her work

Germany's vaccine advisory panel on Thursday recommended that Pfizer-BioNTech's COVID-19 vaccine for children from six months to four years should only be given routinely to those at risk of severe disease from the infection.

Infections from some antibiotic-resistant pathogens known as superbugs have more than doubled in health care facilities in Europe, an EU agency said on Thursday, providing further evidence of the wider impact of the COVID-19 pandemic.

It’s the whispered-about weight loss injection that’s been killing the appetites of influencers, stars and CEOs alike for months. Libby Galvin investigates the craze

The Sedgefield firm said the pandemic had brought the issue of biological threats into sharp focus